PETVIVO TO EXHIBIT SPRYNG® WITH OSTEOCUSHION® TECHNOLOGY AT THE 2026 ACVS SURGERY SUMMIT IN CHARLOTTE, NORTH CAROLINA
https://www.otcmarkets.com/stock/PETV/news/PE...?id=537384
MINNEAPOLIS, MN, October 5, 2026 — PetVivo Holdings, Inc. (OTCQX: PETV) (“PetVivo” or the “Company”), a biomedical device company focused on the commercialization of innovative medical devices and therapeutics for equine and companion animals, today announced that it will exhibit its lead product, Spryng® with OsteoCushion® Technology, at the American College of Veterinary Surgeons (“ACVS”) Surgery Summit, October 7–10, 2026, at the Charlotte Convention Center in Charlotte, North Carolina. Exhibits will be open October 8–9 in Exhibit Hall C.
Spryng is an intra-articular injectable veterinary medical device composed of sterilized extracellular matrix microparticles. The microparticles have been found to adsorb onto the joint synovial lining and subsequently integrate with the animal’s subsynovial tissue. This action promotes the restoration of proper joint mechanics, aiding in the management of noninfectious sources of joint pain, including joint instability, degenerative joint disease and osteoarthritis.
“Veterinary surgeons bring an important perspective to the management of joint disease and the challenges of maintaining mobility in their patients,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “The ACVS Surgery Summit gives us an opportunity to discuss the science behind Spryng, share clinical experience and learn directly from the specialists treating these conditions every day. We look forward to connecting with attendees and discussing how Spryng can fit into their approach to managing joint-related afflictions in horses and companion animals.”
Attendees are invited to visit PetVivo at booth #716 in Exhibit Hall C of the Charlotte Convention Center, 501 S. College Street, Charlotte, North Carolina. The exhibit hall will be open on Thursday, October 8, from 9:00 a.m. to 6:00 p.m., and Friday, October 9, from 9:00 a.m. to 5:00 p.m., Eastern Time. PetVivo representatives will be available to discuss Spryng’s technology, clinical applications and use in veterinary practice.
https://www.otcmarkets.com/stock/PETV/news/PE...?id=537384
MINNEAPOLIS, MN, October 5, 2026 — PetVivo Holdings, Inc. (OTCQX: PETV) (“PetVivo” or the “Company”), a biomedical device company focused on the commercialization of innovative medical devices and therapeutics for equine and companion animals, today announced that it will exhibit its lead product, Spryng® with OsteoCushion® Technology, at the American College of Veterinary Surgeons (“ACVS”) Surgery Summit, October 7–10, 2026, at the Charlotte Convention Center in Charlotte, North Carolina. Exhibits will be open October 8–9 in Exhibit Hall C.
Spryng is an intra-articular injectable veterinary medical device composed of sterilized extracellular matrix microparticles. The microparticles have been found to adsorb onto the joint synovial lining and subsequently integrate with the animal’s subsynovial tissue. This action promotes the restoration of proper joint mechanics, aiding in the management of noninfectious sources of joint pain, including joint instability, degenerative joint disease and osteoarthritis.
“Veterinary surgeons bring an important perspective to the management of joint disease and the challenges of maintaining mobility in their patients,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “The ACVS Surgery Summit gives us an opportunity to discuss the science behind Spryng, share clinical experience and learn directly from the specialists treating these conditions every day. We look forward to connecting with attendees and discussing how Spryng can fit into their approach to managing joint-related afflictions in horses and companion animals.”
Attendees are invited to visit PetVivo at booth #716 in Exhibit Hall C of the Charlotte Convention Center, 501 S. College Street, Charlotte, North Carolina. The exhibit hall will be open on Thursday, October 8, from 9:00 a.m. to 6:00 p.m., and Friday, October 9, from 9:00 a.m. to 5:00 p.m., Eastern Time. PetVivo representatives will be available to discuss Spryng’s technology, clinical applications and use in veterinary practice.
